Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage

a technology of vortioxetine and salt, which is applied in the field of salts of antidepressant vortioxetine and crystalline forms thereof, can solve the problems of not providing the preparation methods or characterization data of the above solvates, isomers or pharmaceutically acceptable salts of vortioxetine, and the form of vortioxetine hydrobromide is very unstable and hygroscopic, and achieves stable and high purity value a vortioxetine salts of vortioxetine salts of vortioxetine salts of vortioxetine salts of vortioxetine salts of vortioxetine salts of vortioxetine and a technology of vortioxetine and a a a a a a a a a a a hygroscopic, hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopic hygroscopi

Inactive Publication Date: 2016-07-14
HANGZHOU PUSHAI PHARMA TECH
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention aims to provide a new form of the drug vortioxetine hemihydrobromide that has better thermal stability and is not affected by humidity. The technical effect of this invention is the creation of a more stable and reliable substance for use in medication. The invention also provides methods for preparing this new form of vortioxetine.

Problems solved by technology

Patent document WO2003 / 029232A1 disclosed free base of vortioxetine and a preparation method thereof, also mentioned its solvates, isomers and pharmaceutically acceptable salts and uses in treating affective disorders. but did not provide preparation methods or characterization data of the above solvates, isomers or pharmaceutically acceptable salts of vortioxetine.
The γ Form of vortioxetine hydrobromide is very unstable and is hygroscopic.
The hydrate of vortioxetine hydrobromide is unstable and is hygroscopic.
The ethyl acetate solvate of vortioxetine hydrobromide is unstable.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage
  • Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage
  • Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0170]Vortioxetine was synthesized by reference to the preparation process in example 24 in patent document WO2007 / 144005A1. The process is specified as follows: Under nitrogen protection, 200 mL of toluene, 40.76 g of sodium tert-butoxide, 0.33 g of Pd(dba)2[Bis(dibenzylideneacetone)palladium] and 0.68 g of rac-BINAP(2,2′-bis(diphenylphosphino)-1,1′-binaphthyl) were successively added to a 500 mL four-neck flask, and then stirring was started, followed by addition of 19.54 g of 2,4-dimethylbenzenethiol. white precipitation came out. 42.00 g of 2-bromo-Iodobenzene was added, kept the reflux reaction heated for 5 h; the reaction mixture was cooled to room temperature and filtered; removed insoluble matters, the filtrate was poured back into a 500 mL four-neck flask, followed by addition of 42.20 g of anhydrous piperazine, 40.76 g of sodium tert-butoxide, 0.33 g of Pd(dba)2 and 0.68 g of rac-BINAP; after refluxing for 2 h, the reaction completed.

[0171]The reaction mixture was cooled t...

preparation example 2

[0176]To 5.00 g (16.8 mmol) of vortioxetine, 125 mL of ethyl acetate was added, heated the solution to 70° C. and the solids were completely dissolved. With the temperature maintained at 70° C. and stirring, 3.4 g of hydrobromic acid (40% w / w, 16.8 mmol) was slowly added dropwise to the vortioxetine solution; solids precipitated out during the dropwise-addition process and the solution gradually turned viscous; 25 mL of ethyl acetate was added, and the solution became flowable; after moved to room temperature and stirred for 4 h, the mixture was filtered under reduced pressure. After drying under vacuum at 40° C. for 24 h, the β Form of vortioxetine hydrobromide was obtained. The yield was 2.00 g (5.3 mmol); the percent yield was 31.5%.

[0177]The XRPD pattern is shown in FIG. 7, which is consistent with the XRPD pattern of the β Form of vortioxetine hydrobromide provided in WO2007 / 144005A1.

example 1

[0178]8.00 g (26.8 mmol) of vortioxetine was dissolved in 122 mL of ethanol by sonication in a 250 mL round-bottom flask; 2.70 g of hydrobromic acid (40% w / w, 13.3 mmol) was dissolved in 16 mL of ethanol by sonication; with stirring, the hydrobromic acid solution was slowly added dropwise to the vortioxetine solution; solids precipitated out during the dropwise-addition process; the solvent was removed by rotary evaporation at 40° C.; after drying under vacuum at 40° C. for 24 h, 8.91 g (13.1 mmol) of white solids of the vortioxetine hemihydrobromide were obtained. The percent yield was 98.5%.

[0179]HPLC characterization indicates the white solids are the vortioxetine hemihydrobromide, formed from vortioxetine and hydrogen bromide at a molar ratio of 2:1. The detailed characterization procedure is: Using vortioxetine as the reference substance, the obtained white solids were accurately weighed and assayed by HPLC to get the weight percent of vortioxetine in the white solids. The weig...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
humidityaaaaaaaaaa
melting pointaaaaaaaaaa
decomposition temperatureaaaaaaaaaa
Login to View More

Abstract

The present invention relates to the novel vortioxetine salts, solvates and crystalline forms thereof, specifically, vortioxetine hemihydrobromide and a crystalline form thereof, and isopropanol solvate of vortioxetine hydrobromide and a crystalline form thereof. Compared to the known vortioxetine hydrobromide, the vortioxetine salts, solvates and crystalline forms of the present invention have improved features in stability, hygroscopicity and purity. The present invention also relates to preparation methods of the vortioxetine salts, solvates and crystalline forms, pharmaceutical compositions thereof and their uses in the manufacture of antidepressant drugs.

Description

FIELD OF THE INVENTION[0001]The present invention relates to salts of antidepressant vortioxetine and crystalline forms thereof, and relates to preparation methods of the salts and crystalline forms thereof, pharmaceutical compositions thereof and their uses in preparing drugs for treating diseases including major depressive disorder, and methods for treating diseases including major depressive disorder as well.BACKGROUND[0002]Vortioxetine is a novel antidepressant developed by Tekeda Pharmaceuticals and H. Lundbeck A / S jointly, and used for the treatment of major depressive disorder. It is considered that the drug acts through a combination of two mechanisms: receptor activity modulation and reuptake inhibition. In vitro studies indicate vortioxetine is a 5-HT3 and 5-HT7 receptor antagonist, a 5-HT1B receptor partial agonist, a 5-HT1A receptor agonist and a 5-HT transporter inhibitor. In vivo nonclinical studies indicate vortioxetine can elevate levels of neurotransmitters (seroton...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D295/096
CPCC07D295/096C07B2200/13A61P25/00A61K31/495A61K9/4866A61K9/2059A61K9/2027A61K9/2054A61K9/0095
Inventor SONG, XIAOYESHENG, XIAOXIASHENG, XIAOHONG
Owner HANGZHOU PUSHAI PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com